The Pseudo‐Natural Product Rhonin Targets RHOGDI
Open Access
- 2 March 2022
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (18) , e202115193
Abstract
For the discovery of novel chemical matter generally endowed with bioactivity, strategies may be particularly efficient that combine previous insight about biological relevance, e.g., natural product (NP) structure, with methods that enable efficient coverage of chemical space, such as fragment‐based design. We describe the de novo combination of different 5‐membered NP‐derived N‐heteroatom fragments to structurally unprecedented “pseudo‐natural products” in an efficient complexity‐generating and enantioselective one‐pot synthesis sequence. The pseudo‐NPs inherit characteristic elements of NP structure but occupy areas of chemical space not covered by NP‐derived chemotypes, and may have novel biological targets. Investigation of the pseudo‐NPs in unbiased phenotypic assays and target identification led to the discovery of the first small‐molecule ligand of the RHO GDP‐dissociation inhibitor 1 (RHOGDI1), termed Rhonin. Rhonin inhibits the binding of the RHOGDI1 chaperone to GDP‐bound RHO GTPases and alters the subcellular localization of RHO GTPases.Keywords
Funding Information
- European Research Council (268309)
- Deutsche Forschungsgemeinschaft (AH 92/8-1, ME 4267/5-1, GO 284/10-1, 390677874 EXC-2033, formerly EXC-1069 the Cluster of Excellence RESOLV ("Ruhr Explores Solvation"))
- Bundesministerium für Forschung, Technologie und Raumfahrt (GeNeRaRe 01GM1902C, the Cluster of Excellence RESOLV ("Ruhr Explores Solvation"))
This publication has 51 references indexed in Scilit:
- Organocatalytic Diastereo‐ and Enantioselective 1,3‐Dipolar Cycloaddition of Azlactones and MethyleneindolinonesAngewandte Chemie International Edition, 2013
- Organocatalytic Diastereo‐ and Enantioselective 1,3‐Dipolar Cycloaddition of Azlactones and MethyleneindolinonesAngewandte Chemie, 2013
- Inhibition of Rac1 promotes BMP-2-induced osteoblastic differentiationCell Death & Disease, 2013
- Hedgehog pathway as a drug target: Smoothened inhibitors in developmentOncoTargets and Therapy, 2012
- The 'invisible hand': regulation of RHO GTPases by RHOGDIsNature Reviews Molecular Cell Biology, 2011
- Gold(I)-Catalyzed Diastereo- and Enantioselective 1,3-Dipolar Cycloaddition and Mannich Reactions of AzlactonesJournal of the American Chemical Society, 2011
- Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1Nature Cell Biology, 2010
- Let’s not forget tautomersJournal of Computer-Aided Molecular Design, 2009
- Recognizing and exploiting differences between RNAi and small-molecule inhibitorsNature Chemical Biology, 2007
- Regulation of Osteoblast Differentiation by Pasteurella Multocida Toxin (PMT): A Role for Rho GTPase in Bone FormationJournal of Bone and Mineral Research, 2004